National Institute of Allergy and Infectious Diseases
Grantee website Bethesda, Maryland, United StatesPurpose
to evaluate malaria vaccines and biologics in standardized assays to accelerate the development of a multistage biologic for prevention and multistage vaccine for eradication of malaria in low and middle income countries.
Grantee
Division
Global Health
Date
DECEMBER 2025
Region served
GLOBAL
Committed amount
$805,916
Grant topic
Discovery and Translational Sciences,
Malaria
Duration (months)
19
Grantee location
Bethesda, Maryland, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.